Loading data
GENYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 45.86 bn USD | 38.7 bn USD | 35.35 bn USD | 29.14 bn USD | 56.47 bn USD |
| Research and development expense | 1.58 bn USD | 1.29 bn USD | 1.01 bn USD | 808 m USD | 1.68 bn USD |
| Selling, general and administrative expense | 4.09 bn USD | 4.44 bn USD | 4.05 bn USD | 3.67 bn USD | 8.18 bn USD |
| Profit before tax | 10 bn USD | 7.62 bn USD | 10.44 bn USD | 1.52 bn USD | -5.7 bn USD |
| Income tax expense | 1.41 bn USD | 962 m USD | 994 m USD | 169 m USD | -757 m USD |
| Net income (reported basis) | 8.7 bn USD | 6.56 bn USD | 9.48 bn USD | 292 m USD | -6.59 bn USD |
| Net income attributable to common shareholders | 8.7 bn USD | 6.56 bn USD | 9.19 bn USD | 48 m USD | -6.57 bn USD |
| Basic earnings per share | 8.2 USD/share | 6.04 USD/share | 8.44 USD/share | 0.05 USD/share | -6 USD/share |
| Diluted earnings per share | 8.14 USD/share | 5.99 USD/share | 8.36 USD/share | 0.05 USD/share | -6 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.